ELRIG Drug Discovery

Liverpool, UK
October 18–19, 2023

Join Genedata experts at the ELRIG Drug Discovery conference in London, UK at booth #F20.

Don't miss the opportunity to see how Genedata Screener^® captures data from all assays, regardless of therapeutic modality or area. It automates analysis of even the most complex assays, on a single platform and in a harmonized manner, to ensure high result quality and better decision-making. You also have the chance to find out more about Genedata Imagence^®. Genedata Imagence lets you train a deep neural network to classify cellular phenotypes in HCS images for unbiased, high-quality results. It automates your analysis to put the power of deep learning algorithms in the hands of assay biologists. To get more information about our software or to arrange a meeting, please contact  screener(at)genedata.com or imagence(at)genedata.com, respectively.

Recommended Oral Presentations

Advancing Antibody Discovery with A Digital Platform: Genedata Screener 
Jeff Almeida-King, Business Account Manager, Genedata, United Kingdom
Spotlight | Monday, October 19 | 2:30 pm – 2:35 pm

Biotherapeutics R&D relies on a range of biological assays that inform screening, optimization, and characterization. In the race to scale up and accelerate discovery and development of new modalities, manual data processing and analysis have become major bottlenecks. Digitalization and automation of data workflows are therefore critical. In this Spotlight, we will present Genedata Screener, a digital platform that automates assay analysis and centralizes data management across the entire antibody discovery workflow.